rs77141223

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_201596.3(CACNB2):​c.1975C>T​(p.Arg659Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000224 in 1,605,158 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R659H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 29)
Exomes 𝑓: 0.00014 ( 1 hom. )

Consequence

CACNB2
NM_201596.3 missense

Scores

4
8
6

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 5.46

Publications

6 publications found
Variant links:
Genes affected
CACNB2 (HGNC:1402): (calcium voltage-gated channel auxiliary subunit beta 2) This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
CACNB2 Gene-Disease associations (from GenCC):
  • Brugada syndrome 4
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • cardiogenetic disease
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.016142339).
BP6
Variant 10-18539716-C-T is Benign according to our data. Variant chr10-18539716-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 190718.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 157 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_201596.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
NM_201596.3
MANE Select
c.1975C>Tp.Arg659Cys
missense
Exon 14 of 14NP_963890.2Q08289-1
CACNB2
NM_201590.3
MANE Plus Clinical
c.1813C>Tp.Arg605Cys
missense
Exon 13 of 13NP_963884.2Q08289-3
CACNB2
NM_201597.3
c.1903C>Tp.Arg635Cys
missense
Exon 14 of 14NP_963891.1Q08289-8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
ENST00000324631.13
TSL:1 MANE Select
c.1975C>Tp.Arg659Cys
missense
Exon 14 of 14ENSP00000320025.8Q08289-1
CACNB2
ENST00000377329.10
TSL:1 MANE Plus Clinical
c.1813C>Tp.Arg605Cys
missense
Exon 13 of 13ENSP00000366546.4Q08289-3
CACNB2
ENST00000352115.10
TSL:1
c.1903C>Tp.Arg635Cys
missense
Exon 14 of 14ENSP00000344474.6Q08289-8

Frequencies

GnomAD3 genomes
AF:
0.00105
AC:
157
AN:
149730
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00357
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000336
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000590
Gnomad OTH
AF:
0.00145
GnomAD2 exomes
AF:
0.000250
AC:
60
AN:
240102
AF XY:
0.000191
show subpopulations
Gnomad AFR exome
AF:
0.00310
Gnomad AMR exome
AF:
0.000213
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000183
Gnomad OTH exome
AF:
0.000348
GnomAD4 exome
AF:
0.000139
AC:
202
AN:
1455390
Hom.:
1
Cov.:
41
AF XY:
0.000131
AC XY:
95
AN XY:
724002
show subpopulations
African (AFR)
AF:
0.00397
AC:
131
AN:
32990
American (AMR)
AF:
0.000208
AC:
9
AN:
43326
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25830
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39680
South Asian (SAS)
AF:
0.0000471
AC:
4
AN:
84924
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52578
Middle Eastern (MID)
AF:
0.000701
AC:
4
AN:
5704
European-Non Finnish (NFE)
AF:
0.0000297
AC:
33
AN:
1110334
Other (OTH)
AF:
0.000333
AC:
20
AN:
60024
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00105
AC:
157
AN:
149768
Hom.:
0
Cov.:
29
AF XY:
0.00115
AC XY:
84
AN XY:
72948
show subpopulations
African (AFR)
AF:
0.00356
AC:
145
AN:
40696
American (AMR)
AF:
0.000335
AC:
5
AN:
14904
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5018
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4688
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9940
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.0000590
AC:
4
AN:
67784
Other (OTH)
AF:
0.00144
AC:
3
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
9
18
26
35
44
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000423
Hom.:
0
Bravo
AF:
0.00135
ESP6500AA
AF:
0.00295
AC:
13
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000330
AC:
40
EpiCase
AF:
0.000164
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Brugada syndrome 4 (1)
-
-
1
CACNB2-related disorder (1)
-
-
1
Cardiovascular phenotype (1)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Uncertain
0.040
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.24
T
Eigen
Uncertain
0.53
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Benign
0.067
D
MetaRNN
Benign
0.016
T
MetaSVM
Uncertain
0.41
D
MutationAssessor
Uncertain
2.1
M
PhyloP100
5.5
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-2.3
N
REVEL
Uncertain
0.64
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0030
D
Polyphen
0.97
D
Vest4
0.64
MVP
0.92
MPC
0.59
ClinPred
0.068
T
GERP RS
5.2
Varity_R
0.34
gMVP
0.11
Mutation Taster
=67/33
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77141223; hg19: chr10-18828645; COSMIC: COSV56620217; COSMIC: COSV56620217; API